Innoviva, Inc.
DE ˙ DB ˙ US45781M1018
19,20 € ↑0,70 (3,78%)
2026-06-04
AKTIENPREIS
SecurityDE:HVE / Innoviva, Inc.
InstitutionSei Investments Co
Latest Disclosed Ownership87,063 shares
Latest Disclosed Value $ 1,740,478
Sei Investments Co reports 86.47% increase in ownership of HVE / Innoviva, Inc.

On February 13, 2026 - Sei Investments Co filed a 13F-HR form disclosing ownership of 87,063 shares of Innoviva, Inc. (DE:HVE) valued at $1,445,246 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 46,690 shares of Innoviva, Inc.. This represents a change in shares of 86.47% during the quarter. The current value of the position is $1,671,610 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F INNOVIVA COM 45781M101 87,063 40,373 86.47 1,740 104.23 0.0017
2025-11-13 2025-09-30 13F INNOVIVA COM 45781M101 46,690 11,543 32.84 852 20.85 0.0009
2025-08-14 2025-06-30 13F INNOVIVA COM 45781M101 35,147 35,147 706 0.0008
2021-05-12 2021-03-31 13F INNOVIVA COM 45781M101 0 -21,007 -100.00 0 -100.00
2021-02-08 2020-12-31 13F INNOVIVA COM 45781M101 21,007 -67,093 -76.16 233 -74.67 0.0006
2020-12-04 2020-09-30 13F/A-1 INNOVIVA COM 45781M101 88,100 39,926 82.88 920 36.70 0.0027
2020-11-06 2020-09-30 13F INNOVIVA COM 45781M101 88,100 39,926 920 2,215.1554
2020-08-17 2020-06-30 13F/A-1 INNOVIVA COM 45781M101 48,174 9,662 25.09 673 48.57 0.0021
2020-08-11 2020-06-30 13F INNOVIVA COM 45781M101 25,175 -13,337 354 960.2438
2020-05-14 2020-03-31 13F INNOVIVA COM 45781M101 38,512 -4,279 -10.00 453 -16.11 0.0017
2020-02-06 2019-12-31 13F INNOVIVA COM 45781M101 42,791 28,866 207.30 540 267.35 0.0016
2019-11-12 2019-09-30 13F INNOVIVA COM 45781M101 13,925 -751 -5.12 147 -31.31 0.0004
2019-08-14 2019-06-30 13F INNOVIVA COM 45781M101 14,676 -3,059 -17.25 214 -14.06 0.0007
2019-05-15 2019-03-31 13F INNOVIVA COM 45781M101 17,735 15,599 730.29 249 654.55 0.0008
2019-02-13 2018-12-31 13F INNOVIVA COM 45781M101 2,136 -47 -2.15 33 -2.94 0.0001
2018-11-08 2018-09-30 13F INNOVIVA COM 45781M101 2,183 -11,749 -84.33 34 -82.38 0.0001
2018-08-03 2018-06-30 13F INNOVIVA COM 45781M101 13,932 710 5.37 193 -12.27 0.0007
2018-05-11 2018-03-31 13F INNOVIVA COM 45781M101 13,222 1,051 8.64 220 27.91 0.0008
2018-02-08 2017-12-31 13F INNOVIVA COM 45781M101 12,171 2,337 23.76 172 24.64 0.0006
2017-11-06 2017-09-30 13F INNOVIVA COM 45781M101 9,834 9,805 33,810.34 138 0.0005
2017-07-31 2017-06-30 13F INNOVIVA COM 45781M101 29 0 0.00 0 0.0000
2017-05-05 2017-03-31 13F INNOVIVA COM 45781M101 29 -229,623 -99.99 0 -100.00
2017-02-02 2016-12-31 13F INNOVIVA COM 45781M101 229,652 -72,365 -23.96 2,457 -25.97 0.0119
2016-11-04 2016-09-30 13F INNOVIVA COM 45781M101 302,017 7,216 2.45 3,319 6.93 0.0169
2016-08-11 2016-06-30 13F INNOVIVA COM 45781M101 294,801 -9,697 -3.18 3,104 -19.04 0.0186
2016-05-10 2016-03-31 13F/A-1 INNOVIVA COM 45781M101 304,498 -808 -0.26 3,834 19.14 0.0239
2016-02-03 2015-12-31 13F THERAVANCE COM 88338T104 305,306 -27,637 -8.30 3,218 34.59 0.0196
2015-11-02 2015-09-30 13F/A-1 THERAVANCE COM 88338T104 332,943 187,059 128.22 2,391 -9.29 0.0219
2015-10-30 2015-09-30 13F DIREXION SHS ETF TR COM 88338T104 332,943 2,392
2015-08-07 2015-06-30 13F/A-1 THERAVANCE COM 88338T104 145,884 62,605 75.18 2,636 101.22 0.0238
2015-08-04 2015-06-30 13F THERAVANCE COM 88338T104 145,884 145,884 2,636 0.0238
2015-05-14 2015-03-31 13F/A-1 THERAVANCE COM 88338T104 83,279 83,240 213,435.90 1,310 130,900.00 0.0114
2015-05-01 2015-03-31 13F THERAVANCE COM 88338T104 83,279 1,310
2015-02-10 2014-12-31 13F THERAVANCE COM 88338T104 39 39 1 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.